NEW YORK (GenomeWeb) – Hologic reported after the close of the market on Wednesday that its fiscal second quarter revenues grew 5 percent year over year as its molecular diagnostic revenues grew more than 6 percent. 

For the three months ended March 28 the Bedford, Mass.-based firm said that it recorded total revenues of $655.5, up from $625 million in the year-ago quarter. It beat the average analysts' estimate of $645.6 million. 

On a constant currency basis, revenues were up 7 percent, Hologic said. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Microsoft co-founder Paul Allen also contributed to brain research, NPR reports.

The New York Times reports on the shifting interpretations of what some genetic variants mean over time.

In Cell this week: investigation of metastatic tumor evolution, more than 16,000 genetic variants introduced into the budding yeast model organism, and more.

MIT's Technology Review reports on Genentech's pursuit of personalized cancer vaccines.